Half Year 2026 Formycon AG Earnings Call Transcript
Key Points
- Formycon AG (WBO:FYB) reported a significant revenue increase, nearly tripling compared to H1 2025, driven by strong performance from FYB202 and FYB206.
- The company achieved a major milestone with the successful launch of FYB203, its third pipeline product, in Europe, expanding its commercial portfolio.
- Formycon AG (WBO:FYB) improved its adjusted EBITDA by EUR12.3 million year-over-year, reflecting better cost control and operational efficiency.
- The company secured strategic partnerships, including a manufacturing deal with OneSource and a license agreement with Lotus for APAC markets, enhancing its global footprint.
- Formycon AG (WBO:FYB) confirmed its full-year guidance, with expectations of continued growth in H2 2026, supported by strong commercial indicators for FYB202 and FYB206.
- Formycon AG (WBO:FYB) experienced a decrease in cash and cash equivalents to EUR51.8 million, impacted by prepayments and operational investments.
- Royalty revenues for FYB202 were below expectations in H1 2026, with a challenging market environment and slower-than-anticipated momentum.
- The company's joint venture Bioeq AG contributed negatively to adjusted EBITDA due to the relaunch of FYB201 in the US, which is expected to turn around only in H2 2026.
- Formycon AG (WBO:FYB) faces intense competition and tender pressures in Europe, particularly for FYB202, which may limit market share gains.
- The company's reliance on milestone-based revenue recognition for FYB206 introduces uncertainty, as future payments depend on regulatory and partnership milestones.
Good afternoon, ladies and gentlemen, and welcome to the Formycon AG Earnings Call H1 2026. The conference will be recorded. At this time, all participants have been placed in listen-only mode. The floor will be open for questions following the presentation within the conference call. Let me now turn the floor over to your host, Dr. Stefan Glombitza.
Thank you and good afternoon, good morning, and welcome to everyone joining us today. With the publication of our Q2 and H1 2026 results earlier today, we have reached another important milestone in our financial year. Before we turn to the details of the presentation, let me just highlight a few key takeaways that reflect the significant progress we have achieved in the first six months of this year. First, our H1 financial performance shows substantial year-on-year growth.
Which is underscoring the disciplined execution of our strategy and confirming the momentum we are building across our business. Just as a reminder, our business is not linear
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
